Hemoglobin A1C (HbA1C) Testing

World Market Report

MCP-1218

EXECUTIVE ENGAGEMENTS

POOL

5872
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

942
Interactions with Platform & by Email

PARTICIPANTS

176
Unique # Participated

VALIDATIONS

38
Responses Validated*

COMPANIES

110
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

214

PAGES

511

EDITION

17

PRICE

USD 5450

CODE

MCP-1218


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Hemoglobin A1C (HbA1C) Testing Market to Reach $1.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$723.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunoassays segment is readjusted to a revised 8.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $341.7 Million, While China is Forecast to Grow at 9% CAGR
The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$341.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$208.6 Million by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 6.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$184.2 Million by the year 2027.

Boronate Affinity Chromatography Segment to Record 6% CAGR
In the global Boronate Affinity Chromatography segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$147.2 Million in the year 2020 will reach a projected size of US$216.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.3% CAGR through the analysis period.

SELECT PLAYERS

A.Menarini Diagnostics Ltd.; Abbott Laboratories; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Diazyme Laboratories, Inc.; EKF Diagnostics Holdings Plc; HemoCue® AB; OSANG Healthcare Co., Ltd; PTS Diagnostics; Roche Diagnostics; Siemens Healthineers; Trinity Biotech plc

SEGMENTS

» Technology (Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays, Other Technologies) » End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Year 2021 in Review and Near-term Outlook
Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
Competition
Hemoglobin A1C (HbA1C) Testing – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2022 (E)
HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
Role of HbA1c Testing in Diabetes Diagnosis and Management
Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association
Global Market Analysis and Prospects
World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth
While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth
Chromatography-based Hb Testing Devices Lead Market
HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes
Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing
Recent Market Activity
WORLD BRANDS
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices
EXHIBIT 1: World Diabetes and Population Statistics (2019, 2030 & 2045)
EXHIBIT 2: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
EXHIBIT 3: World Diabetes Prevalence (2000-2045P)
EXHIBIT 5: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Diabetes Emerges as One of the Leading Causes of Mortality
EXHIBIT 6: Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
Laboratory-based HbA1c Testing Products/Analyzers of Select Players
Major Testing Methods in POC HbA1c Tests
High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
EXHIBIT 9: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT 10: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Obesity Levels Underpins Market Growth
EXHIBIT 13: Average Per Capita Annual Health Expenditure (In US$) due to Obesity
EXHIBIT 14: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
EXHIBIT 11: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Variants & Derivatives Affecting Accuracy of HbA1c Testing
Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
EXHIBIT 18: Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
EXHIBIT 19: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
Technology Developments Transform Diagnostics in Diabetes Care
Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
Home HbA1C Testing Market
4. GLOBAL MARKET PERSPECTIVE
World Hemoglobin A1C (HbA1C) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
MIDDLE EAST
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
AFRICA
Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com